Congratulations @UrologyEDGH Impressive retrospective study.
Great work Ms Rushton! https://t.co/a1zMIPWyo9
US BCG shortage is having a real effect on treatment of bladder cancer patients. There appears no end to the BCG shortage. @CombatCancer is treating patients @DukeUrology using #HIVEC treatment under IND @DukeCancer . https://t.co/XYAwv1cptD
US BCG shortage is having a real effect on treatment of bladder cancer patients. There appears no end to the BCG shortage. @CombatCancer is treating patients @DukeUrology using #HIVEC treatment under IND @DukeCancer . https://t.co/XYAwv1cptD
Dr. Fernando Álvarez was interviewed on TV about the new system for chemohyperthermia installed in HM IMI Toledo. https://t.co/fKporZSKRM
An interview with Dr. Fernando Álvarez from Hospital HM IMI Toledo celebrating the first system installed in Castilla La Mancha. Interview starts at 57 min.
Toledo en la Onda 27/06/2019
Podcast del programa Toledo en la Onda, con Paula Fernández
www.ondacero.es
Unit of surgical oncology @HUReinaSofia has performed 20 cytoreductive surgeries plus HIPEC by laparoscopic approach, a better recovery is offered to selected patients with peritoneal carcinomatosis @operarelcancer @GECOP_ @me4_so @SPeritoneum @EAES_eu @AnnSurgOncol @aecirujanos
Enjoying being invited to @TelB2BEvents #TelegraphFTE and listening to inspiring speech by @liamfox on UK being central to global export going forward. #freetrade
@CombatCancer #HIVEC #BAUS2019 Thank-you @drtanws for presenting BCG unresponsive series multicentre analysis, head to stand 310 to discuss this and other data presented so far this year
Good to see @nikhilvasdevuro today at #BAUS2019 Thanks for stopping by to discuss @CombatCancer #HIVEC
#HIVEC @CombatCancer #BAUS19 Great results presented by @drtanws at #baus19 in BCG Unresponsive series using #HIVEC
Come join us at Stand 310 to hear our new data to treat HR NMIBC #BAUS19 #CombatCancer #HIVEC
#HIVEC #HIPEC @CombatCancer #BAUS19 Looking forward to BAUS 2019, visit us on stand 310, abstract presentation, Monday 24th 12-1pm, hope to see you there.
Segundo e ultimo día de la VIII Reunion Internacional GECOP & VI Congreso Nacional SEOQ en Murcia - visita nuestro stand para saber mas de HIPEC+Agitación por CO2 @operarelcancer @GECOP_ @CombatCancer @ESSOnews #HIPEC #PRS
Presentation of: Multicenter Study in Survival of patients undergoing CRS + Closed HIPEC with CO2 Agitation System @operarelcancer @ESSOnews @GECOP_ @CombatCancer #PRS #HIPEC
40 patients took part in the study, split into two groups – one which received the HIVEC™ treatment prior to a resection of the bladder, and another which received HIVEC after resection of the bladder.
97% of the patients were able to complete the full course of HIVEC treatments, and the majority of participants responded well to the treatment and show low rates of recurrence. Furthermore, the majority of the side-effects were low grade and had very little effect on the treatment plan.
Click Here to read the full article
Click Here to read the interview with the research author
